美国急性呼吸衰竭与ARDS死亡率的趋势及地理差异
该研究回顾性分析美国国家卫生统计中心2014至2018年全国死亡数据,评估急性呼吸衰竭(ARF)与ARDS相关死亡趋势及2018年地理分布。共纳入1,434,349例ARF相关死亡和52,958例ARDS相关死亡。ARF年龄调整死亡率从2014年74.9/10万升至2018年85.6/10万(APC 3.4,95%CI 2.2-4.6,Ptrend=.003);ARDS死亡率2014年3.2/10万、2018年3.0/10万(APC -0.9,95%CI -5.4至3.8,Ptrend=.56),无显著下降。老年人(≥65岁)、非西班牙裔黑人及非都市区人群死亡率最高,2018年南部地区ARF与ARDS死亡率均最高。
要点
- ARF年龄调整死亡率从2014年74.9/10万升至2018年85.6/10万,APC 3.4(95%CI 2.2-4.6),各年龄、性别、种族、城乡和地区亚组均一致上升。
- ARDS年龄调整死亡率2014年3.2/10万、2018年3.0/10万,APC -0.9(95%CI -5.4至3.8,Ptrend=.56),5年内未见下降。
- 死亡率最高人群为≥65岁老年人、非西班牙裔黑人和非都市区居民。
- 2018年南部地区ARF死亡率91.3/10万(95%CI 90.8-91.8)、ARDS死亡率3.3/10万(95%CI 3.2-3.4),均为全美最高。
- 研究期间共1,434,349例ARF相关死亡和52,958例ARDS相关死亡,提示ARF死亡负担远高于ARDS。
适用人群与场景
- 纳入2014至2018年美国全国死亡登记数据中的全部美国居民,按年龄、性别、种族、城乡化和地区分层;原文未提及具体的纳入或排除标准。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:基于美国国家卫生统计中心全国死亡数据的回顾性分析;研究期2014至2018年;共1,434,349例ARF相关死亡和52,958例ARDS相关死亡。
- 主要终点:ARF年龄调整死亡率(每10万人)从2014年74.9(95%CI 74.6-75.2)升至2018年85.6(95%CI 85.3-85.9),APC 3.4(95%CI 2.2-4.6),Ptrend=.003。
- ARDS年龄调整死亡率2014年为3.2(95%CI 3.2-3.3)、2018年为3.0(95%CI 3.0-3.1),APC -0.9(95%CI -5.4至3.8),Ptrend=.56。
- 亚组:ARF死亡率上升在年龄、性别、种族或族裔、城乡化状态和地理区域各亚组中均一致(所有Ptrend<.05);死亡率最高者为≥65岁、非西班牙裔黑人和非都市区人群。
- 2018年南部地区ARF死亡率91.3(95%CI 90.8-91.8)、ARDS死亡率3.3(95%CI 3.2-3.4),均为最高。
证据类型、等级与局限
- 证据类型:基于全国死亡登记数据的回顾性观察性分析;原文未给出证据等级或推荐强度。
- 局限:原文未明确列出局限;设计本身为回顾性、依赖死亡登记数据,原文未提及是否可校正编码或混杂因素。
对床旁实践的改变
- 提示急诊与ICU应关注ARF死亡负担持续上升,尤其在≥65岁、非西班牙裔黑人和非都市区人群中;ARDS死亡率5年未见下降。
- 原文未提供任何具体临床处置、药物或流程推荐,不能据此改变抢救室或ICU的具体治疗做法。
- 数据来自死亡登记,属于人群层面的趋势与地理分布,不能用于个体患者的风险分层或决策阈值。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite numerous advances in the understanding of the pathophysiology, progression, and management of acute respiratory failure (ARF) and ARDS, limited contemporary data are available on the mortality burden of ARF and ARDS in the United States.
RESEARCH QUESTION: What are the contemporary trends and geographic variation in ARF and ARDS-related mortality in the United States?
STUDY DESIGN AND METHODS: A retrospective analysis of the National Center for Health Statistics' nationwide mortality data was conducted to assess the ARF and ARDS-related mortality trends from 2014 through 2018 and the geographic distribution of ARF and ARDS-related deaths in 2018 for all American residents. Piecewise linear regression was used to evaluate the trends in age-adjusted mortality rates (AAMRs) in the overall population and various demographic subgroups of age, sex, race, urbanization, and region.
RESULTS: Among 1,434,349 ARF-related deaths and 52,958 ARDS-related deaths during the study period, the AAMR was highest in older individuals (≥ 65 years), non-Hispanic Black people, and those living in the nonmetropolitan region. The AAMR for ARF-related deaths (per 100,000 people) increased from 74.9 (95% CI, 74.6-75.2) in 2014 to 85.6 (95% CI, 85.3-85.9) in 2018 (annual percentage change [APC], 3.4 [95% CI, 2.2-4.6]; Ptrend = .003). The AAMR (per 100,000 people) for ARDS-related deaths was 3.2 (95% CI, 3.2-3.3) in 2014 and 3.0 (95% CI, 3.0-3.1 in 2018; APC, -0.9 [95% CI, -5.4 to 3.8]; Ptrend = .56). The observed increase in rates for ARF mortality was consistent across the subgroups of age, sex, race or ethnicity, urbanization status, and geographical region (Ptrend < .05 for all). The AAMR (per 100,000 people) for ARF (91.3 [95% CI, 90.8-91.8]) and ARDS-related mortality (3.3 [95% CI, 3.2-3.4]) in 2018 were highest in the South.
INTERPRETATION: The ARF-related mortality increased at approximately 3.4% annually, and ARDS-related mortality showed a lack of decline in the last 5 years. These data contextualize important health information to guide priorities for research, clinical care, and policy, especially during the coronavirus disease 2019 pandemic in the United States.
参考来源
- Parcha V, Kalra R, Bhatt SP, et al. Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States. Chest. 2020. PMID: 33393472. doi:10.1016/j.chest.2020.10.042
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。